Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

Prostate Cancer Clinical Trial

Official title:

Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00581672
• Other study ID #: 07-125
• Status: Completed
• Start date: July 25, 2010
• Est. completion date: May 3, 2022

Study information

• Verified date: May 2022
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

Other known NCT identifiers

• NCT00602654

Recruitment information / eligibility

• Status: Completed
• Enrollment: 224
• Est. completion date: May 3, 2022
• Est. primary completion date: May 3, 2022
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age or older

• Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results

• Diagnosis of prostate cancer

• Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).

• Ability to comprehend and complete questionnaires in English

Exclusion Criteria:

• Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol

• Other non-Black or non-African-American ethnic groups

Related Conditions & MeSH terms

• Prostate Cancer
• Prostatic Neoplasms

Intervention

Behavioral:
• questionnaires of quality of life
Subjects will be asked to complete the MAX-PC along with additional psychosocial questionnaires which include anxiety, depression coping methods, resilience spirituality, religiosity, and quality of life measures and will take approximately one 30 to 45 minutes to complete by patient.

Locations

Country	Name	City	State
United States	Downstate Medical Center	Brooklyn	New York
United States	Kings County Hopsital Center	Brooklyn	New York
United States	Memorial Sloan Kettering Cancer Center	New York	New York

Sponsors (4)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	Kings County Hospital Center, State University of New York - Downstate Medical Center, University School of Medicine(VA-NYU)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.		within one to three weeks of receiving their PSA scores from their physician
Secondary	To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer.		within one to three weeks of receiving their PSA scores from their physician

External Links

•   Memorial Sloan Kettering Web Site